THE BEAUTY HEALTH COMPANY CL A
Reported by THE BANK OF NEW YORK MELLON CORPORATION
Reported 373,738 shares, up 36,138 (10.7%) from the prior quarter.
Reported value -15.7%; share count 10.7% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2021-12-31 | 8872000 |
| 2022-03-31 | 5699000 |
| 2022-06-30 | 4807000 |
| 2022-09-30 | 5025000 |
| 2022-12-31 | 2854343 |
| 2023-03-31 | 3669963 |
| 2023-06-30 | 2287286 |
| 2023-09-30 | 1646078 |
| 2023-12-31 | 860216 |
| 2024-03-31 | 1237779 |
| 2024-06-30 | 668368 |
| 2024-09-30 | 405702 |
| 2024-12-31 | 419194 |
| 2025-03-31 | 310920 |
| 2025-06-30 | 580823 |
| 2025-09-30 | 616603 |
| 2025-12-31 | 420894 |
| 2026-03-31 | 258589 |
| 2026-06-30 | 0 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q2 2026 | Reduced | 0 | -290,550 (-100.0%) | 0 | $0 | 2026-08-06 | |
| Q1 2026 | Reduced | 290,550 | -12,251 (-4.0%) | < 0.01% | $258,589 | 2026-05-05 | |
| Q4 2025 | Reduced | 302,801 | -7,050 (-2.3%) | < 0.01% | $420,894 | 2026-02-10 | |
| Q3 2025 | Added | 309,851 | +5,755 (1.9%) | < 0.01% | $616,603 | 2025-11-03 | |
| Q2 2025 | Added | 304,096 | +72,066 (31.1%) | < 0.01% | $580,823 | 2025-08-05 | |
| Q1 2025 | Reduced | 232,030 | -31,614 (-12.0%) | < 0.01% | $310,920 | 2025-04-29 | |
| Q4 2024 | Reduced | 263,644 | -18,094 (-6.4%) | < 0.01% | $419,194 | 2025-02-04 | |
| Q3 2024 | Reduced | 281,738 | -66,370 (-19.1%) | < 0.01% | $405,702 | 2024-11-12 | |
| Q2 2024 | Added | 348,108 | +69,329 (24.9%) | < 0.01% | $668,368 | 2024-07-25 | |
| Q1 2024 | Added | 278,779 | +2,182 (0.8%) | < 0.01% | $1,237,779 | 2024-04-25 | |
| Q4 2023 | Added | 276,597 | +3,162 (1.2%) | < 0.01% | $860,216 | 2024-01-29 | |
| Q3 2023 | Added | 273,435 | +163 (0.1%) | < 0.01% | $1,646,078 | 2023-10-24 | |
| Q2 2023 | Reduced | 273,272 | -17,303 (-6.0%) | < 0.01% | $2,287,286 | 2023-08-03 | |
| Q1 2023 | Reduced | 290,575 | -23,089 (-7.4%) | < 0.01% | $3,669,963 | 2023-05-09 | |
| Q4 2022 | Reduced | 313,664 | -112,566 (-26.4%) | < 0.01% | $2,854,343 | 2023-02-14 | |
| Q3 2022 | Added | 426,230 | +52,492 (14.0%) | < 0.01% | $5,025,000 | 2022-11-14 | |
| Q2 2022 | Added | 373,738 | +36,138 (10.7%) | < 0.01% | $4,807,000 | 2022-08-15 | |
| Q1 2022 | Reduced | 337,600 | -29,655 (-8.1%) | < 0.01% | $5,699,000 | 2022-05-11 | |
| Q4 2021 | Added | 367,255 | +23,705 (6.9%) | < 0.01% | $8,872,000 | 2022-02-11 | |
|
Five years are shown. A free account unlocks the complete reported history.
Unlock full history
|
|||||||
Who else reported the position
184 managers reported THE BEAUTY HEALTH COMPANY CL A for Q2 2022.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| FMR LLC | Added | 22,594,751 | +5,044 | 0.03% | $290,568,498 | 5 qtrs |
| VANGUARD GROUP INC | Added | 9,684,147 | +157,052 | < 0.01% | $124,539,000 | 5 qtrs |
| JANUS HENDERSON GROUP PLC | Added | 9,469,576 | +3,715,879 | 0.08% | $121,780,000 | 5 qtrs |
| BAMCO INC NY | Added | 7,168,184 | +2,929,313 | 0.3% | $92,183,000 | 5 qtrs |
| BlackRock Inc | Reduced | 6,452,166 | -1,326,223 | < 0.01% | $82,976,000 | 5 qtrs |
| WILLIAM BLAIR INVESTMENT MANAGEMENT LLC | Reduced | 6,048,627 | -83,539 | 0.29% | $77,785,000 | 5 qtrs |
| Redmile Group LLC | Reduced | 5,186,348 | -118,157 | 2.55% | $66,696,000 | 5 qtrs |
| Luxor Capital Group LP | Added | 3,705,481 | +2,060,007 | 2.08% | $47,652,000 | 5 qtrs |
| Soleus Capital Management L P | Added | 3,276,037 | +3,048,425 | 6.57% | $42,130,000 | 5 qtrs |
| Senvest Management LLC | Added | 2,709,347 | +557,011 | 1.19% | $34,842,000 | 5 qtrs |
Filing details and methodology As reported
- Report period
- June 30, 2022
- Filed
- August 15, 2022
- Filing type
- 13F-HR
- Position type
- COM
Voting authority reported
- Sole
- 332,763
- Shared
- 0
- None
- 40,975
“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.